Carbutamide
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | A10BB06 (WHO) |
| Identifiers | |
| |
| CAS Number |
339-43-5 |
| PubChem (CID) | 9564 |
| ChemSpider |
9189 |
| UNII |
E3K8P4869P |
| ChEMBL |
CHEMBL448570 |
| ECHA InfoCard | 100.005.841 |
| Chemical and physical data | |
| Formula | C11H17N3O3S |
| Molar mass | 271.335 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.
It is classified as first-generation.[1]
References
- ↑ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Res. Clin. Pract. 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
This article is issued from Wikipedia - version of the 8/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
